FI950730A - Menetelmä ei-toivottujen solujen tai kudosten kasvun tuhoamiseksi tai ehkäisemiseksi - Google Patents

Menetelmä ei-toivottujen solujen tai kudosten kasvun tuhoamiseksi tai ehkäisemiseksi Download PDF

Info

Publication number
FI950730A
FI950730A FI950730A FI950730A FI950730A FI 950730 A FI950730 A FI 950730A FI 950730 A FI950730 A FI 950730A FI 950730 A FI950730 A FI 950730A FI 950730 A FI950730 A FI 950730A
Authority
FI
Finland
Prior art keywords
destroying
tissues
growth
preventing
unwanted cells
Prior art date
Application number
FI950730A
Other languages
English (en)
Swedish (sv)
Other versions
FI950730A0 (fi
Inventor
Anna Richter
David Dolphin
Julia G Levy
Original Assignee
Quadra Logic Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quadra Logic Tech Inc filed Critical Quadra Logic Tech Inc
Publication of FI950730A0 publication Critical patent/FI950730A0/fi
Publication of FI950730A publication Critical patent/FI950730A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
FI950730A 1992-08-17 1995-02-17 Menetelmä ei-toivottujen solujen tai kudosten kasvun tuhoamiseksi tai ehkäisemiseksi FI950730A (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US93016592A 1992-08-17 1992-08-17
PCT/CA1993/000328 WO1994004147A1 (en) 1992-08-17 1993-08-17 Method for destroying or inhibiting growth of unwanted cells or tissues
CN93116757A CN1099612A (zh) 1992-08-17 1993-09-03 破坏或抑制不需要的细胞或组织生长的方法

Publications (2)

Publication Number Publication Date
FI950730A0 FI950730A0 (fi) 1995-02-17
FI950730A true FI950730A (fi) 1995-04-10

Family

ID=36869960

Family Applications (1)

Application Number Title Priority Date Filing Date
FI950730A FI950730A (fi) 1992-08-17 1995-02-17 Menetelmä ei-toivottujen solujen tai kudosten kasvun tuhoamiseksi tai ehkäisemiseksi

Country Status (9)

Country Link
US (1) US5945439A (fi)
EP (1) EP0654993A1 (fi)
JP (1) JPH08505361A (fi)
CN (1) CN1099612A (fi)
AU (1) AU4695493A (fi)
CA (1) CA2142711A1 (fi)
FI (1) FI950730A (fi)
NO (1) NO950610L (fi)
WO (1) WO1994004147A1 (fi)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5693789A (en) * 1996-04-10 1997-12-02 Abbott Laboratories Process for the preparation of a protoporphyrin
CA2206203A1 (en) * 1997-05-27 1998-11-27 University Of British Columbia Photoactivation of endogenous porphyrins for treatment of psoriasis
AU6427299A (en) 1998-10-13 2000-05-01 Brown University Research Foundation Substituted perhalogenated phthalocyanines
AU2001227837A1 (en) * 2000-01-12 2001-07-24 Light Sciences Corporation Novel treatment for eye disease
DE10020935A1 (de) * 2000-04-28 2001-11-08 Alfons Hofstetter Verwendung von Photofrin als Radiosensitizer
WO2002064163A2 (en) 2001-02-15 2002-08-22 Qlt Inc. Reduction or prevention of pdt related inflammation
US7018371B2 (en) * 2001-05-07 2006-03-28 Xoft, Inc. Combination ionizing radiation and radiosensitizer delivery devices and methods for inhibiting hyperplasia
US7090691B2 (en) * 2001-11-09 2006-08-15 Qlt Inc. Photodynamic therapy for the treatment of hair loss
DE60307545T2 (de) * 2002-06-21 2007-10-04 Adair, Edwin L., Castle Pines Village Anwendung von Metalloporphyrinen zur Behandlung von Arteriosklerose
US20040110731A1 (en) * 2002-12-04 2004-06-10 Chan Agnes H. Photodynamic therapy for the treatment of non-melanoma skin cancer
JP2008503217A (ja) 2004-06-18 2008-02-07 アンブレツクス・インコーポレイテツド 新規抗原結合ポリペプチド及びそれらの使用
JP4525683B2 (ja) * 2004-12-03 2010-08-18 Ｊｓｒ株式会社 反射防止膜形成用組成物、積層体およびレジストパターンの形成方法
US7465312B2 (en) 2006-05-02 2008-12-16 Green Medical, Inc. Systems and methods for treating superficial venous malformations like spider veins
WO2007130465A2 (en) * 2006-05-02 2007-11-15 Green Medical, Inc. Systems and methods for treating superficial venous malformations like spider veins
EP2192922A4 (en) 2007-09-17 2010-09-29 Univ California INTERNALIZING HUMAN MONOCLONAL ANTIBODIES TARGING PROSTATE <I> IN SITU CANCER CELLS </ I>
US10029115B2 (en) * 2011-04-08 2018-07-24 Sanovas Intellectual Property, Llc Photodynamic therapy for tumors with localized delivery
WO2017095823A1 (en) 2015-11-30 2017-06-08 The Regents Of The University Of California Tumor-specific payload delivery and immune activation using a human antibody targeting a highly specific tumor cell surface antigen
WO2018089807A2 (en) 2016-11-11 2018-05-17 The Regents Of The University Of California Anti-cd46 antibodies and methods of use
TW202039573A (zh) 2018-12-21 2020-11-01 美商亞維代堤生物科學公司 抗轉鐵蛋白受體抗體及其用途
EP4121063A1 (en) 2020-03-19 2023-01-25 Avidity Biosciences, Inc. Compositions and methods of treating facioscapulohumeral muscular dystrophy
IL296393A (en) 2020-03-27 2022-11-01 Avidity Biosciences Inc Preparations and methods for the treatment of muscle atrophy
KR20230066149A (ko) 2020-08-07 2023-05-12 포티스 테라퓨틱스, 인크. Cd46을 표적화하는 면역접합체 및 이의 사용 방법
WO2023043953A1 (en) 2021-09-16 2023-03-23 Avidity Biosciences, Inc. Compositions and methods of treating facioscapulohumeral muscular dystrophy

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4649151A (en) * 1982-09-27 1987-03-10 Health Research, Inc. Drugs comprising porphyrins
US4920143A (en) * 1987-04-23 1990-04-24 University Of British Columbia Hydro-monobenzoporphyrin wavelength-specific cytotoxic agents
US5095030A (en) * 1987-01-20 1992-03-10 University Of British Columbia Wavelength-specific cytotoxic agents
US4883790A (en) * 1987-01-20 1989-11-28 University Of British Columbia Wavelength-specific cytotoxic agents
US5091385A (en) * 1988-09-30 1992-02-25 Baylor Research Institute Pre-activated therapeutic agents derived from photoactive compounds

Also Published As

Publication number Publication date
EP0654993A1 (en) 1995-05-31
CN1099612A (zh) 1995-03-08
FI950730A0 (fi) 1995-02-17
US5945439A (en) 1999-08-31
NO950610D0 (no) 1995-02-17
CA2142711A1 (en) 1994-03-03
WO1994004147A1 (en) 1994-03-03
JPH08505361A (ja) 1996-06-11
NO950610L (no) 1995-03-16
AU4695493A (en) 1994-03-15

Similar Documents

Publication Publication Date Title
FI950730A0 (fi) Menetelmä ei-toivottujen solujen tai kudosten kasvun tuhoamiseksi tai ehkäisemiseksi
DE69330169D1 (de) Visuell gesteuerter trokar
DE69432815D1 (de) Wachstumsfaktor-8
DE69329660T2 (de) IMPLANTIERBARE ANSATZSTüCKE
DE69228531T2 (de) Implantierbarer Knochenwachstumsstimulator
DE69426414T2 (de) Implantatmaterial
DE69318689D1 (de) Implantierbarer Herzschittmacher
ATE146665T1 (de) Osteosynthesehilfsmittel
DE69624739T2 (de) Aktiv-Puls-Magnetometer
DE69308725D1 (de) Trokar
DE59209679D1 (de) Implantat zur elektrischen Impulsbeaufschlagung von lebendem Gewebe
ATE198275T1 (de) Subkutane implantate bestehend aus nomgestrolderivaten
DE9219054U1 (de) Operationsmikroskop
DE69310500T2 (de) Racemisierungsverfahren
DE59207772D1 (de) Frequenzadaptierender Herzschrittmacher
IT1271567B (it) Procedimento per l&#39;ulteriore trattamento di salcicce
DE69300316D1 (de) Kathodischer Elektrotauchlack.
DE69433986D1 (de) Visuell gesteuerter trokar
ATA27793A (de) Mehrschariger pflug
NO933216D0 (no) Implantat
GB2268673B (en) Artificial lures
DK72592A (da) Trocar
FR2670814B3 (fr) Module d&#39;algues artificielles.
RU1827194C (ru) Способ разрушени биологических тканей
HU9303272D0 (en) I or cross sectional metalprofile for trusses

Legal Events

Date Code Title Description
FD Application lapsed